Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of Menorrhagia
article
OA: closed
CC0
⤵ 52 in-corpus citations
AI-generated summary
Naproxen, oral contraceptives, and danazol all reduced menstrual blood loss in women with menorrhagia, with danazol showing a further reduction after the first treatment cycle.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A series of 45 ovulatory women with a complaint of menorrhagia were randomized into 3 treatment groups, before receiving therapy with mefenamic acid in 2 cycles and 1 of 3 other agents in 2 cycles: naproxen (group 1; n = 14), a low dose monophasic combined oral contraceptive (group 2; n = 12) or low dose danazol (group 3; n = 12). Menstrual blood loss was measured in 2-4 control cycles and during therapy. Mefenamic acid reduced measured blood loss by 20%; 38%; and 39% in groups 1-3 respectively. Naproxen reduced blood loss by 12%; the oral contraceptive by 43%; and danazol by 49%. There was no statistically significant difference in blood loss reduction (mean of 2 cycles) between any of the treatments, although women on danazol experienced a dramatic and highly significant further reduction in blood loss after the first treatment cycle (p less than 0.003). These were all effective therapies in a majority of women, but some 'non-responders' were seen in each group. The 'non-responders' had a significantly lower pretreatment blood loss than responders. Several women in group 1 showed anomalous responses to prostaglandin inhibitors with consistent and substantial exacerbation of menorrhagia during therapy. A number of reasonable therapies exist for the medical treatment of menorrhagia, but because none is suitable for everyone management needs to be individualized for each patient.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- 11 Treatment of menorrhagia via openalex
- An Objective Evaluation of Flurbiprofen and Tranexamic Acid in the Treatment of Idiopathic Menorrhagia via openalex
- Comparison between mefenamic acid and danazol in the treatment of established menorrhagia via openalex
- Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid via openalex
- Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex
- REDUCTION OF MENSTRUAL BLOOD LOSS BY DANAZOL IN UNEXPLAINED MENORRHAGIA: LACK OF EFFECT OF PLACEBO via openalex
- REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS via openalex
- W2154327088 via openalex
- W4239570023 via openalex
- W1783602832 via openalex
- W2042374015 via openalex
- W2083517870 via openalex
- W2086126831 via openalex
- W2097047879 via openalex
- W2099229592 via openalex
Cited by (50)
- Variation of outcome reporting in studies of interventions for heavy menstrual bleeding: a systematic review 2022
- Non-contraceptive Benefits of Hormonal Methods 2021
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2019
- Quantitative bias analysis of a reported association between perfluoroalkyl substances (PFAS) and endometriosis: The influence of oral contraceptive use 2017
- National consensus of management patients with abnormal uterine bleeding by association of gynecologist and endocrinologist of Ukraine 2015
- A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial 2015
- Medical Management of Heavy Menstrual Bleeding 2015
- Nonsurgical Management of Heavy Menstrual Bleeding 2013
- Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest 2013
- Heavy menstrual flow: current and future trends in management. 2013
- Clinical use of oral contraceptives 2013
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2013
- Hysterectomy and levonorgestrel-releasing intrauterine system in the treatment of menorrhagia : a 10-year randomized comparative trial 2012
- Treatment of Heavy Menstrual Bleeding with the Estradiol Valerate and Dienogest Oral Contraceptive Pill 2012
- Medical treatment of idiopathic heavy menstrual bleeding. What is new? An evidence based approach 2012
- Pharmacological therapy for abnormal uterine bleeding 2011
- Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest 2011
- Use of combined oral contraceptives for the management of heavy menstrual bleeding 2011
- Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest 2011
- Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest 2011
- Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial 2011
- Estradiol Valerate and Dienogest: A Novel Four-Phasic Oral Contraceptive Pill Effective for Pregnancy Prevention and Treatment of Heavy Menstrual Bleeding 2011
- The hyperexpressions of putative stem cells in the eutopic endometrium of patients with advanced endometriosis 2010
- Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest 2010
- Contraception and gynaecological care 2009
- Non-contraceptive benefits of oral contraceptives 2008
- Hiérarchisation des stratégies thérapeutiques pour ménométrorragies avec ou sans désir de grossesse 2008
- Non-contraceptive health benefits of oral contraceptives 2008
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding 2007
- Danazol for heavy menstrual bleeding 2007
- Abnormal Uterine Bleeding: A Management Algorithm 2006
- Noncontraceptive health benefits of combined oral contraception 2005
- Treatment of abnormal uterine bleeding with micronized flavonoids 2005
- Medical management of menorrhagia 2005
- Benefits and Risks of Pharmacological Agents Used for the Treatment of Menorrhagia 2004
- Medical management of dysfunctional uterine bleeding 2003
- Current treatment of dysfunctional uterine bleeding 2003
- Danazol for heavy menstrual bleeding 2002
- Dysfunctional uterine bleeding: advances in diagnosis and treatment 2001
- Altered uterine artery blood flow impedance after danazol therapy: possible mode of action in dysfunctional uterine bleeding 1999
- Medical management of dysfunctional uterine bleeding 1999
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding 1998
- A double-blind randomised study comparing danazol and medroxyprogesterone acetate in the management of menorrhagia 1998
- A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss 1997
- Medical Management of Menorrhagia in Pre- and Perimenopausal Women 1997
- Menorrhagia: a clinical update 1996
- Treating Menorrhagia in Primary Care: <i>An Overview of Drug Trials and a Survey of Prescribing Practice</i> 1995
- Managing menorrhagia. 1995
- 8 Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders 1992
- Treatment of Menorrhagia 1992
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK